Northwestern Mutual Wealth Management’s Foghorn Therapeutics FHTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.3K	Buy	+5,295	New	+$29.1K	﹤0.01%	2713

Other funds holding FHTX

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Northwestern Mutual Wealth Management's FHTX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Foghorn Therapeutics (FHTX) in Q1 2026: 5,295 shares worth $25.3K. The stake represents ﹤0.01% of the portfolio and ranks #2713 among its holdings.

105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

Northwestern Mutual Wealth Management held 5,295 shares of Foghorn Therapeutics worth $25.3K as of Q1 2026.
Foghorn Therapeutics was a new Northwestern Mutual Wealth Management position in Q1 2026.
Foghorn Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #2713 holding.
105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.